These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 32829374

  • 1. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
    Fan LL, Chen X, Zhang XY, Li ZM, Fan XM, Shen Y.
    Med Sci Monit; 2020 Aug 23; 26():e922612. PubMed ID: 32829374
    [Abstract] [Full Text] [Related]

  • 2. Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice.
    Chen X, Zhang XY, Shen Y, Fan LL, Ren ML, Wu YP.
    Oncotarget; 2016 Dec 13; 7(50):83451-83461. PubMed ID: 27825139
    [Abstract] [Full Text] [Related]

  • 3. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
    Kong QW, Yang J, Li D, Ding YW, Hu YJ, Xue XC, Shi MZ, Jiang B, Zhou YY, Zhang M, Hu JD, Guo C, Chen JJ, Han YL.
    J Ethnopharmacol; 2023 Jan 10; 300():115728. PubMed ID: 36126783
    [Abstract] [Full Text] [Related]

  • 4. Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line.
    Shen Y, Zhang XY, Chen X, Fan LL, Ren ML, Wu YP, Chanda K, Jiang SW.
    Oncol Rep; 2017 Jan 10; 37(1):219-226. PubMed ID: 27878277
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells.
    Lu M, Xiao L, Li Z.
    J Huazhong Univ Sci Technolog Med Sci; 2007 Dec 10; 27(6):725-8. PubMed ID: 18231754
    [Abstract] [Full Text] [Related]

  • 8. Octreotide reverses the resistance of A2780/Pacliaxel ovarian cancer cell line to paclitaxel chemotherapy in vitro.
    Shen Y, Zhang XY, Chen X, Ren ML, Cai YL.
    J Cancer Res Ther; 2016 Dec 10; 12(2):657-62. PubMed ID: 27461627
    [Abstract] [Full Text] [Related]

  • 9. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN, Zhao LJ, Wu LN, He MF, Qu JW, Zhao YB, Zhao WZ, Li JS, Wang JH.
    Asian Pac J Cancer Prev; 2013 Dec 10; 14(9):4983-8. PubMed ID: 24175763
    [Abstract] [Full Text] [Related]

  • 10. Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.
    Lu M, Xiao L, Hu J, Deng S, Xu Y.
    J Huazhong Univ Sci Technolog Med Sci; 2008 Aug 10; 28(4):451-5. PubMed ID: 18704310
    [Abstract] [Full Text] [Related]

  • 11. CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.
    Tang XH, Li H, Zheng XS, Lu MS, An Y, Zhang XL.
    Cancer Med; 2019 Oct 10; 8(14):6426-6436. PubMed ID: 31490008
    [Abstract] [Full Text] [Related]

  • 12. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH, Seong MA, Lee HY.
    Oncotarget; 2016 Feb 16; 7(7):8184-99. PubMed ID: 26799187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells.
    Feng J, Peng Z, Gao L, Yang X, Sun Z, Hou X, Li E, Zhu L, Yang H.
    Biomed Pharmacother; 2021 Jun 16; 138():111407. PubMed ID: 33765585
    [Abstract] [Full Text] [Related]

  • 15. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
    Tang XH, Lu MS, Deng S, Li M.
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr 25; 54(4):255-261. PubMed ID: 31006192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.